131 related articles for article (PubMed ID: 6196552)
1. Effect of adenosine deaminase inhibitors on the heart's functional and biochemical recovery from ischemia: a study utilizing the isolated rat heart adapted to 31P nuclear magnetic resonance.
Dhasmana JP; Digerness SB; Geckle JM; Ng TC; Glickson JD; Blackstone EH
J Cardiovasc Pharmacol; 1983; 5(6):1040-7. PubMed ID: 6196552
[TBL] [Abstract][Full Text] [Related]
2. Metabolic and functional consequences of inhibiting adenosine deaminase during renal ischemia in rats.
Stromski ME; van Waarde A; Avison MJ; Thulin G; Gaudio KM; Kashgarian M; Shulman RG; Siegel NJ
J Clin Invest; 1988 Nov; 82(5):1694-9. PubMed ID: 3263396
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of PHA and NaI04 mitogenesis by the adenosine deaminase inhibitors erythro-9-(2-hydroxy-3-nonyl) adenine (EHNA) and 2-deoxycoformycin (2-dCF).
Lum CT; Sutherland DE; Najarian JS
Clin Immunol Immunopathol; 1979 Apr; 12(4):453-9. PubMed ID: 222523
[No Abstract] [Full Text] [Related]
4. Protective effects of an adenosine deaminase inhibitor on ischemia-reperfusion injury in isolated perfused rat heart.
Zhu QY; Chen SG; Zou CM
Am J Physiol; 1990 Sep; 259(3 Pt 2):H835-8. PubMed ID: 2396691
[TBL] [Abstract][Full Text] [Related]
5. Adenosine deaminase inhibitors attenuate ischemic injury and preserve energy balance in isolated guinea pig heart.
Sandhu GS; Burrier AC; Janero DR
Am J Physiol; 1993 Oct; 265(4 Pt 2):H1249-56. PubMed ID: 8238412
[TBL] [Abstract][Full Text] [Related]
6. Degradation of adenosine by extracellular adenosine deaminase in the rat duodenum.
Franco R; Hoyle CH; Centelles JJ; Burnstock G
Gen Pharmacol; 1988; 19(5):679-81. PubMed ID: 3265122
[TBL] [Abstract][Full Text] [Related]
7. Separation between ischemic and reperfusion injury by site specific entrapment of endogenous adenosine and inosine using NBMPR and EHNA.
Abd-Elfattah AS; Wechsler AS
J Card Surg; 1994 May; 9(3 Suppl):387-96. PubMed ID: 8069025
[TBL] [Abstract][Full Text] [Related]
8. Effects of adenosine deaminase inhibitors on lymphocyte-mediated cytolysis.
Wolberg G; Zimmerman TP
Ann N Y Acad Sci; 1985; 451():215-26. PubMed ID: 3878118
[TBL] [Abstract][Full Text] [Related]
9. Synergistic effect of 3'-deoxyadenosine N1-oxide and adenosine deaminase inhibitors on growth of Ehrlich ascites tumor cells in vivo.
Svendsen KR; Overgaard-Hansen K; Frederiksen S
Cancer Chemother Pharmacol; 1988; 21(1):35-9. PubMed ID: 3257721
[TBL] [Abstract][Full Text] [Related]
10. Suppression of human lymphocyte DNA and protein synthesis in vitro by adenosine and eight modified adenine nucleosides in the presence or in the absence of adenosine deaminase inhibitors, 2'-deoxycoformycin (DCF) and erythro-9-(2-hydroxy-3-nonyl) adenine (EHNA).
Ratech H; Kuritsky L; Thorbecke GJ; Hirschhorn R
Cell Immunol; 1982 Apr; 68(2):244-51. PubMed ID: 6980056
[No Abstract] [Full Text] [Related]
11. Differential cardioprotection with selective inhibitors of adenosine metabolism and transport: role of purine release in ischemic and reperfusion injury.
Abd-Elfattah AS; Jessen ME; Lekven J; Wechsler AS
Mol Cell Biochem; 1998 Mar; 180(1-2):179-91. PubMed ID: 9546645
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of inhibition of adenosine deaminase by erythro-9-(2-hydroxy-3-nonyl)adenine in CBA mice.
Lambe CU; Nelson DJ
Biochem Pharmacol; 1982 Feb; 31(4):535-9. PubMed ID: 7066021
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the activity of 2'-deoxycoformycin and erythro-9-(2-hydroxy-3-nonyl)adenine in vivo.
Plunkett W; Alexander L; Chubb S; Loo TL
Biochem Pharmacol; 1979; 28(2):201-6. PubMed ID: 426835
[No Abstract] [Full Text] [Related]
14. [Adenosine deaminase inhibitor (EHNA) on ischemia-reperfusion injury in isolated perfused rat hearts].
Zhu Q
Zhonghua Xin Xue Guan Bing Za Zhi; 1990 Apr; 18(2):107-9, 127. PubMed ID: 2209402
[TBL] [Abstract][Full Text] [Related]
15. Intermittent aortic crossclamping prevents cumulative adenosine triphosphate depletion, ventricular fibrillation, and dysfunction (stunning): is it preconditioning?
Abd-Elfattah AS; Ding M; Wechsler AS
J Thorac Cardiovasc Surg; 1995 Aug; 110(2):328-39. PubMed ID: 7637350
[TBL] [Abstract][Full Text] [Related]
16. Adenosine deaminase inhibitors enhance cerebral anoxic hyperemia in the rat.
Phillis JW; DeLong RE; Towner JK
J Cereb Blood Flow Metab; 1985 Jun; 5(2):295-9. PubMed ID: 3872875
[TBL] [Abstract][Full Text] [Related]
17. Adenosine deaminase inhibitor in cardioplegia enhanced function preservation of the hypothermically stored rat heart.
Zhu Q; Yang X; Claydon MA; Hicks GL; Wang T
Transplantation; 1994 Jan; 57(1):35-40. PubMed ID: 8291112
[TBL] [Abstract][Full Text] [Related]
18. Adenosine and hypoxic vasodilatation.
Dóra E
J Cereb Blood Flow Metab; 1985 Dec; 5(4):621-4. PubMed ID: 3877069
[No Abstract] [Full Text] [Related]
19. Hemolysis in mice treated with deoxycoformycin, an inhibitor of adenosine deaminase.
Smith CM; Belch A; Henderson JF
Biochem Pharmacol; 1980 Apr; 29(8):1209-10. PubMed ID: 6966932
[No Abstract] [Full Text] [Related]
20. Pharmacokinetics of 2'-deoxycoformycin, an inhibitor of adenosine deaminase, in the rat.
Geiger JD; Lewis JL; MacIntyre CJ; Nagy JI
Neuropharmacology; 1987 Sep; 26(9):1383-7. PubMed ID: 3499581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
